297 related articles for article (PubMed ID: 27224898)
1. Off-Label Uses of Topical Calcineurin Inhibitors.
Wong E; Kurian A
Skin Therapy Lett; 2016 Jan; 21(1):8-10. PubMed ID: 27224898
[TBL] [Abstract][Full Text] [Related]
2. Off-label Uses of Topical Pimecrolimus.
Ladda M; Sandhu V; Ighani A; Yeung J
J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
[TBL] [Abstract][Full Text] [Related]
3. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
Wollina U
Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
[TBL] [Abstract][Full Text] [Related]
4. Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders.
Guenther L; Lynde C; Poulin Y
J Cutan Med Surg; 2019; 23(4_suppl):27S-34S. PubMed ID: 31476936
[TBL] [Abstract][Full Text] [Related]
5. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
6. [Use of medicinal plants and preparations from them to treat various skin diseases].
Mirakhmedov UM; Belova LV
Vestn Dermatol Venerol; 1983 Jul; (7):23-7. PubMed ID: 6226161
[No Abstract] [Full Text] [Related]
7. Topical corticosteroids. Which drug and when?
Giannotti B; Pimpinelli N
Drugs; 1992 Jul; 44(1):65-71. PubMed ID: 1379911
[TBL] [Abstract][Full Text] [Related]
8. [Fluorandrenolone for the local therapy of various dermatoses, including psoriasis vulgaris].
Jänner M
Med Klin; 1963 Sep; 58(36):1469-71. PubMed ID: 4232836
[No Abstract] [Full Text] [Related]
9. Off-label uses of topical vitamin D in dermatology: a systematic review.
Wat H; Dytoc M
J Cutan Med Surg; 2014; 18(2):91-108. PubMed ID: 24636434
[TBL] [Abstract][Full Text] [Related]
10. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
Hong CH; Gooderham M; Bissonnette R
J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
[TBL] [Abstract][Full Text] [Related]
11. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
12. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
Hu W; Xu Y; Ma Y; Lei J; Lin F; Xu AE
Clin Drug Investig; 2019 Dec; 39(12):1233-1238. PubMed ID: 31522334
[TBL] [Abstract][Full Text] [Related]
15. [Tacrolimus in diseases other than atopic dermatitis].
Alomar A; Corella F; García-Navarro X
Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():26-35. PubMed ID: 18346427
[TBL] [Abstract][Full Text] [Related]
16. Topical macrolide immunomodulators: a role in the treatment of vitiligo?
Tjioe M; Vissers WH; Gerritsen MJ
Am J Clin Dermatol; 2006; 7(1):7-12. PubMed ID: 16489839
[TBL] [Abstract][Full Text] [Related]
17. Use of pimecrolimus cream in disorders other than atopic dermatitis.
Day I; Lin AN
J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
[TBL] [Abstract][Full Text] [Related]
18. [Off-label indications for topical tacrolimus].
Hengge UR
Hautarzt; 2013 Oct; 64(10):752-6. PubMed ID: 24150824
[TBL] [Abstract][Full Text] [Related]
19. What's new in the topical treatment of allergic skin diseases.
Aslam I; Sandoval LF; Feldman SR
Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):436-50. PubMed ID: 25061854
[TBL] [Abstract][Full Text] [Related]
20. What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?
Hanna S; Zip C; Shear NH
J Cutan Med Surg; 2019; 23(4_suppl):19S-26S. PubMed ID: 31476938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
